{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:51:25Z","timestamp":1761630685757},"reference-count":14,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2014,5,2]],"date-time":"2014-05-02T00:00:00Z","timestamp":1398988800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplant Infectious Dis"],"published-print":{"date-parts":[[2014,6]]},"abstract":"Abstract<\/jats:title>Background<\/jats:title>A transmission of human immunodeficiency virus (HIV<\/jats:styled-content>) from a live kidney donor prompted recommendations by the New York State Department of Health and the US<\/jats:styled-content> Centers for Disease Control and Prevention that all live donors undergo additional screening for HIV<\/jats:styled-content>, hepatitis B virus (HBV<\/jats:styled-content>), and hepatitis C virus (HCV<\/jats:styled-content>) within 7\u201314\u00a0days of the donation procedure. There are concerns that re\u2010screening will result in delays and cancelled transplants.<\/jats:p><\/jats:sec>Methods<\/jats:title>We surveyed live\u2010donor transplant centers in New York State to assess their screening protocols and outcomes. Nine live\u2010donor programs (kidney and liver centers) responded.<\/jats:p><\/jats:sec>Results<\/jats:title>All but 1 program has a formal repeat screening policy. Overall, no cancellations occurred, but 2 centers experienced transplantation delays, generally as the result of technician and laboratory procedural mistakes necessitating repeat phlebotomy. Testing is typically coordinated with pre\u2010surgical visits, additional laboratory tests, and physical examinations. In the initial evaluation, serology was most frequently used (all 9 centers), with few centers utilizing nucleic acid testing (NAT<\/jats:styled-content>) (HIV NAT<\/jats:styled-content>, 1; HBV NAT<\/jats:styled-content>, 2; HCV NAT<\/jats:styled-content>, 2). Repeat testing modalities varied: HIV<\/jats:styled-content> antibody (5, 55%), HIV NAT<\/jats:styled-content> (8, 88%), hepatitis B surface antigen (5, 55%), hepatitis B surface antibody (2, 22%), hepatitis B core antibody (3, 33%), HBV NAT<\/jats:styled-content> (3, 33%), HCV<\/jats:styled-content> antibody (3, 33%), and HCV NAT<\/jats:styled-content> (5, 55%).<\/jats:p><\/jats:sec>Conclusion<\/jats:title>Most respondents have policies to re\u2010test living donors within 14\u00a0days of the transplant procedures. Rarely, centers encountered repeat testing\u2010associated delays, but no cancellations occurred.<\/jats:p><\/jats:sec>","DOI":"10.1111\/tid.12219","type":"journal-article","created":{"date-parts":[[2014,5,2]],"date-time":"2014-05-02T12:02:41Z","timestamp":1399032161000},"page":"403-411","source":"Crossref","is-referenced-by-count":8,"title":["Impact of repeat testing of living kidney donors within 14\u00a0days of the transplant procedure: a multicenter retrospective survey"],"prefix":"10.1111","volume":"16","author":[{"given":"I.A.","family":"Echenique","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases Northwestern University Feinberg School of Medicine Chicago Illinois USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Cohen","sequence":"additional","affiliation":[{"name":"Division of Nephrology Columbia University College of Physicians and Surgeons New York New York USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.L.","family":"Rudow","sequence":"additional","affiliation":[{"name":"Recanati Miller Transplant Institute Mt. Sinai Hospital New York New York USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.G.","family":"Ison","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases Northwestern University Feinberg School of Medicine Chicago Illinois USA"},{"name":"Organ Transplantation Northwestern University Feinberg School of Medicine Chicago Illinois USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,5,2]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2011.03493.x"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12094"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12095"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2012.04139.x"},{"issue":"10","key":"e_1_2_7_6_1","first-page":"297","article-title":"HIV transmitted from a living organ donor\u2013New York City, 2009","volume":"60","author":"CDC","year":"2011","journal-title":"MMWR Morbid Mortal Wkly Rep"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1177\/003335491312800403"},{"issue":"8","key":"e_1_2_7_8_1","first-page":"1","article-title":"Guidelines for preventing transmission of human immunodeficiency virus through transplantation of human tissue and organs","volume":"43","author":"Centers for Disease Control and Prevention","year":"1994","journal-title":"MMWR Morbid Mortal Wkly Rep"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis555"},{"key":"e_1_2_7_10_1","volume-title":"Health Advisory: Interim recommendations for screening of potential living organ donors for Human Immunodeficiency Virus (HIV), Hepatitis C Virus (HCV), and Hepatitis B Virus (HBV)","author":"New York State Department of Health","year":"2011"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12205"},{"key":"e_1_2_7_12_1","volume-title":"Achieving Consensus on Increased Risk Donors to Improve Access to Organ Transplantation","author":"Ison MG"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2009.02992.x"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2008.02522.x"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2009.02593.x"}],"container-title":["Transplant Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftid.12219","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/tid.12219","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T15:24:13Z","timestamp":1695569053000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tid.12219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,2]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["10.1111\/tid.12219"],"URL":"https:\/\/doi.org\/10.1111\/tid.12219","archive":["Portico"],"relation":{},"ISSN":["1398-2273","1399-3062"],"issn-type":[{"value":"1398-2273","type":"print"},{"value":"1399-3062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,2]]}}}